ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0007094;mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1801.8011146821202;6.781341354126479;0.060304661792685066;0.8093530769822879;[PLK1, BUB1B, CENPF, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[SMARCAL1, CCNH, SMC3, CHEK1, TRIM25, ESCO2, PRKDC, CDCA5, RAD21, BARD1, POLA1, FEN1, BTG2, BRCA1, BRCA2, CHAF1B, CHAF1A, ACTL6A, PARP9, SIRT1, RAD51C, PCNA, UNG, RAD54B, USP1, RAD54L, APBB1, PMS1, GINS2, RPA1, GTF2H1, MLH1, RPA3, TRIP13, DCLRE1A, RUVBL2, RUVBL1, MEN1, LIG1, MSH6, MSH2, FANCD2, TIMELESS, BLM, RNASEH2A, PSMD14, FANCI, HMGA1, ISG15, FANCG, COPS5, JMY, CDK1, EXO1, TOPBP1, RFC5, RFC3, RFC4, RFC1, RFC2, H2AFX, SMC1A, DTL, UHRF1, POLD3, CDC45, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RAD50, RAD51, POLE2]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[MSH6, FANCI, BLM, DONSON, CDK1, TOPBP1]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[TOP2A, ZWILCH, BUB1B, BRCA1, KNTC1, TOPBP1, MSH6, MSH2, MAD1L1, BLM, AURKB, NAE1, BUB1, FANCI, TGFB1, PLK2, PLK1, DONSON, CDC6, ZWINT, WEE1, CENPF, CDK1, TRIP13, MAD2L1, BCL2L1]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, GATA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, ASPM, KITLG, SFRP2, NASP, MSH2, KIT, BCL2, BCL2L1]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[CCNH, RFC5, RFC3, RFC4, RFC1, LIG1, RFC2, PCNA, POLD3, POLD1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RPA1, GTF2H1, COPS5, RPA3]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, PCSK5, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, AP1S2, HOMER3, CUBN, PRKCB, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, PLEKHF2, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, F2RL1, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:1904976;cellular response to bleomycin;7.0;1.0;0.8509193652572005;9.628524252492122;332.1079197183639;9.083926447120524;0.011115353195250678;0.8154717862087246;[TIMELESS]
GO:0048754;branching morphogenesis of an epithelial tube;6.0;0.7436939687323844;0.6949672969563367;8.8813098506619;51.7127811195946;4.956792062075433;0.0017307802455913577;0.5766108891590862;[NRP1, PLXND1, CTSZ, IHH, PHB2, HOXA11, HHEX, EDNRA, HOXA5, MED1, EDN1, HNF1B, PAX2, GREM1, SFRP2, COL4A1, TIMELESS, ENG, EPHA2, LEF1, PAK1, TGFB1, EGF, VDR, PML, PPP1CA, BMP2, BCL2]
GO:0048639;positive regulation of developmental growth;5.0;0.6417349323569144;0.6111084780393774;8.270400768338927;76.48976962833;4.677207199856271;0.002560043753136772;0.5294336055739484;[CYFIP1, NRP1, CPNE5, GHR, BASP1, AKT1, PLS1, GHSR, MEF2C, EDN1, TGFBR3, MAP1B, PLCB1, YAP1, PRKDC, NEDD4L, DLL1, PAK1, CCNB1, HLX, SYT2, FN1, IGF1, MAPK14, VIL1, GH1, CXCL12, RPS6KB1, CDK1, BCL2]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[DTYMK, TYMS, NME1]
GO:0002638;negative regulation of immunoglobulin production;7.0;0.7980440201809971;0.7499413753476991;9.193206181234276;77.13462423321295;7.474488534686424;0.0025816264564307383;0.7331650565203278;[IL33, BCL6, PRKDC, FCRL3, FCGR2B, IL13RA2]
GO:0032201;telomere maintenance via semi-conservative replication;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;216.32599304453976;6.7325511899570465;0.0072402363064467505;0.719302980950052;[RFC5, RFC3, FEN1, PCNA, RFC4, RFC1, RFC2, PRIM1, RPA1, POLD3, POLA1, POLA2, POLD1, RPA3]
GO:0071930;negative regulation of transcription involved in G1/S transition of mitotic cell cycle;11.0;1.0;0.9324289523296623;9.628524252492122;1849.0626671205805;8.67846133901236;0.061886463420164586;0.8762458687964789;[E2F1, E2F7]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, AP1S2, HLA-DOA, HLA-DOB, CTSD, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, KIF4A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0090502;RNA phosphodiester bond hydrolysis, endonucleolytic;8.0;0.6799073451904818;0.7149536725952409;8.878218658092228;231.13671471601307;5.395046993006588;0.007735937832006836;0.6509029541176994;[POP5, FEN1, RNASEH2A, EXO1, RNASE2]
GO:0045814;negative regulation of gene expression, epigenetic;7.0;0.7671156992804218;0.7344772148974115;9.081980546124052;80.1036275103501;5.2552850506314295;0.0026809963241870454;0.6196748871422394;[CREBZF, SPI1, SUV39H1, BMI1, H2AFX, SIRT1, DNMT1, EZH2]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[PCNA, POLD3, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, GTF2H1, RPA3]
GO:1900264;positive regulation of DNA-directed DNA polymerase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1106.254199480119;7.9853141584524145;0.03702533249245755;0.8236103492792612;[RFC5, RFC3, RFC4, RFC2]
GO:0043111;replication fork arrest;10.0;0.8436909121759173;0.837086467948879;9.546846221477855;1135.309178205509;7.9853141584524145;0.037997776482613155;0.8236103492792612;[MSH6, MSH2, TIMELESS]
GO:0006297;nucleotide-excision repair, DNA gap filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;6.641579411751319;0.0049883058697239;0.6905700452391912;[RFC5, RFC3, PCNA, RFC4, RFC1, LIG1, RFC2, RPA1, POLD3, POLD1, RPA3]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, DNMT1, IQGAP3, RASGRP1, G3BP2, JUN, HACE1, PLK2, DHCR24, IGF1, COL1A2, BCL6, LAT, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, NRAS, PDPN, EPS8L1, EPS8L3]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, PRKDC, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, CASP2, SFN, MLH1, TNFRSF1B, SIRT1, PML, MSH6, MSH2, BCL3, BCL2, EPHA2, BCL2L1]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, RNASEH2A, LIG1, RPA1, MLH1, MSH6, POLD3, MSH2, EXO1, RPA3, PMS1]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[HMGB2, CHAF1B, CHAF1A, RUVBL1, BRD2, H2AFX, PADI4, MCM2, HIST1H2BK, CENPA, H1FX, NASP, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO]
GO:0006335;DNA replication-dependent nucleosome assembly;8.0;1.0;0.875;9.628524252492122;163.41517932017535;7.474488534686424;0.005469358987733092;0.7572456912631272;[CHAF1B, CHAF1A, NASP]
GO:0000077;DNA damage checkpoint;8.0;0.811012628672052;0.780506314336026;9.456673995565463;85.75736069739153;5.486614186532078;0.002870221685927797;0.655585704652903;[BLM, CHEK1, E2F1, TOPBP1, FANCI, H2AFX, DONSON, MAPK14, MSH6, MSH2, CDK1]
GO:0071480;cellular response to gamma radiation;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;6.444869117505266;0.0020214916980741903;0.6805102716434839;[YAP1, EGR1, CDKN1A, H2AFX, NOX4, BCL2L1]
GO:0000076;DNA replication checkpoint;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;54.456905800140625;6.8867018697843045;0.0018226236290973575;0.7271862538851576;[CDT1, CDC45, TIMELESS, CDC6, TOPBP1, NAE1]
GO:0051256;mitotic spindle midzone assembly;5.0;1.0;0.7902410118609202;9.628524252492122;55.94550109770304;7.474488534686424;0.001872445574057981;0.6724867031240476;[RACGAP1, KIF4A, AURKB]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, CSE1L, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, RANBP6, PML, NUP35, RAN]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[SPARC, SPINT2, AKT1, PDGFRB, MED1, MEF2C, POSTN, RUNX2, SPINT1, COL4A2, CALCA, TWIST1, GATA3, ADAMTS12, EPB41L5, PDGFD, PLCG1, TGFB1, EGR3, VCAM1, CAV1, COL1A1, VIL1, NR4A1, BMP2, ID1, NOX4, SNAI2, FBN1, NRP1, MCM7, TMEM100, IL10, EDN1, ANXA1, ARG1, CAD, TNFRSF1B, PAX2, CCNA2, XCL1, GAS1, CX3CR1, DTYMK, HDAC2, THBS1, CCL5, E2F1, CCL2, FYN, SNCA, MAPK14, KLF4, RPS6KB1]
GO:0010424;DNA methylation on cytosine within a CG sequence;11.0;1.0;0.9324289523296623;9.628524252492122;392.68740709589525;9.777073627680469;0.01314289411977762;0.9324289523296623;[DNMT1]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, RAN, MAD2L1]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[CTSZ, IHH, PCSK6, PCSK5, CTSS, PLAU, CTSH, CASP2, CTSG, PRSS3, MME, RIPK2, F3, ASPH, UQCRC1, PIK3C3, UQCRC2, ENPEP, C1R, HM13, CD5L, PSEN2, TMPRSS2, AEBP1, PERP, ACE, F11, DHCR24]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[CHEK1, SLBP, BLM, RNASEH2A, BARD1, CDT1, CDC6, POLA1, POLA2, NASP, CDK1, ACHE, FEN1, MCM7, BRCA1, CHAF1B, CHAF1A, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, RMI1, DBF4, MCM3, MCM4, MCM6, DTL, MCM2, CDC45, POLD1, RBBP8, RRM1, RRM2, RPA1, DONSON, RAD50, POLE2, RPA3, DNAJA3, SSBP1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFITM1, SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, NOX4, SNAI2, SRPX, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, STAT1, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[SLBP, POLD1, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, DONSON, POLE2, DNAJA3, SSBP1]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, PRKCD, H2AFX, HMGA1, MAPK14, SIRT1, PML]
GO:0042276;error-prone translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.7325511899570465;0.025467164394386097;0.7595439928109722;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, POLE2, RPA3]
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;7.0;1.0;0.8509193652572005;9.628524252492122;76.30875120206336;6.375876246018314;0.0025539852293156346;0.6769819729871445;[BCL2A1, DCC, IL1A, IL1B, BCL2, CASP2, BCL2L1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0006303;double-strand break repair via nonhomologous end joining;9.0;0.8933024483968273;0.8428918493787028;9.548481544818586;368.8093148901945;5.8067817141283475;0.012343715862540626;0.693199712083778;[DCLRE1A, BLM, PSMD14, PRKDC, BRCA1, BARD1, H2AFX, MLH1, POLA1, RAD50]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, HTRA1, MAPK14, ASCL2, PTK2, DCN, PHLDA2, E2F7, BIRC2]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[CTSZ, FASLG, MYB, CASP2, JUN, TGFB2, CDC34, IL1B, UBE2M]
GO:0006268;DNA unwinding involved in DNA replication;8.0;0.8259837884571596;0.7879918942285797;9.34084218004034;24.41922106263308;7.57984905034425;8.172893530941673E-4;0.7626338329336335;[PURA, RAD51, MCM7, HMGA1, RPA1, MCM4, MCM6, MCM2]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, PRKDC, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:2001229;negative regulation of response to gamma radiation;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;40.32079556071187;9.777073627680469;0.0013495007410569318;0.7902410118609202;[PRKDC]
GO:0002218;activation of innate immune response;8.0;0.622025257344104;0.686012628672052;8.529911963824013;265.7077617868092;4.551326953967268;0.008892999665543976;0.6077550720842344;[FCN1, CLEC10A, ICAM2, ICAM3, PYCARD, PRKACB, PRKCE, CD180, PRKCD, MUC3B, CLEC4A, CLEC4D, BTK, CLEC4E, S100A9, S100A8, CARD11, PRKDC, LY96, KLRK1, CLEC7A, PLCG2, S100A14, CD14, MAP2K6, LYN, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, TNFAIP3, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, DDX58, RIPK2, IRAK3, TLR1, HCK, IRF7, TLR8, TLR10, TLR7, PIK3C3, TLR6, TLR5, TLR4, TLR2, COLEC12, UNC93B1, NLRC4, NOD2, LILRA2, HSPD1, RELB, PAK1, NRAS, FYN, CARD9, NR1H4, TNIP3]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PRKDC, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, IGF1, PML, EREG, BTC, CCNA2, CDK6, NDUFS4]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, ECT2, MYH10, CEP55, CDT1, PLK1, CKAP2, CIT, KIF4A, KIF20A]
GO:0060707;trophoblast giant cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;7.292166977892469;0.0014155633914202197;0.6631627702307852;[PLK4, LIF, NR2F2, E2F7]
GO:0031297;replication fork processing;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;150.6515651586252;6.375876246018314;0.005042172308252987;0.701062607729944;[SMARCAL1, BLM, PCNA, BRCA2, RAD51]
GO:0016233;telomere capping;8.0;1.0;0.875;9.628524252492122;185.09737597092234;7.069023426578259;0.00619504259692348;0.7365101867784198;[RAD50, PRKDC]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[RFC5, RFC3, PCNA, RFC4, RFC1, RFC2, RPA1, RPA3]
GO:2000773;negative regulation of cellular senescence;7.0;1.0;0.8509193652572005;9.628524252492122;164.4250159730019;7.004484905440688;0.005503157311709213;0.7091290490632969;[CDK6, BCL6, PRKDC, PLK2, TWIST1, SLC30A10, SIRT1]
GO:0016458;gene silencing;7.0;0.6835726970475526;0.6927057137809769;8.659123695304018;69.21166146355857;4.8942717050940985;0.002316452022733967;0.6012126478626229;[FMR1, SUV39H1, BMI1, NCBP2, H2AFX, SIRT1, KCNQ1, DNMT1, CNOT3]
GO:1902065;response to L-glutamate;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;96.09026658308662;7.474488534686424;0.0032160547469104574;0.7053660038532718;[PCNA, ABCB4, FYN]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[GINS2, MCM7, CDC6, POLA1, PURA, POLA2, CDC34, CDC45, CCNE2, CCNE1, MCM3, MCM4, MCM6, TOPBP1, MCM2]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[BCL11B, FZD5, PRKDC, FZD8, MAFB, DNAJA3, BCL2, CCR6]
GO:0006272;leading strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;8.67846133901236;0.008899953129253659;0.8400575416471059;[POLA1, PCNA]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[BLM, FEN1, PSMD14, BRCA1, BRCA2, RAD54B, CDC45, RBBP8, RAD54L, GINS2, H2AFX, RPA1, RAD50, RAD51, RAD51C, RPA3]
GO:0043137;DNA replication, removal of RNA primer;8.0;0.9326813400603323;0.8413406700301662;9.593432932680852;683.7334329296626;8.390779266560578;0.022883942680016138;0.8041048419030481;[FEN1, RNASEH2A]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, CASP2, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, ADARB1, PPP2R1A, AKT1, EPHB2, PAQR3, PRKCD, SFRP2, PRKAR1B, TRIB1, ATF3, PRKDC, TWIST1, THY1, PRKCZ, SAMSN1, FLRT2, PRKAR2B, SFN, LYN, JUN, GADD45B, PLK1, LIF, NR2F2, CALM3, PKIG, CDKN1A, PTPRR, LRRC4, TIMP3, DUSP2, DUSP3, DUSP1, BGN, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, FAM129A, NTF3, DMD, CDKN2C, PODN, NLRP12, F2RL1, PKN1, PYCARD, MEN1, CISH, IGFBP3, TSC2, FBLN1, FOXO1, SOCS2, CCNB1, TGFB1, CAV1, PTPRC, CDK6, GNAQ, LRRK2, TNFAIP3, PTPN22, ARRB1, ARRB2, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, PDE4D, IRAK3, DCN, GREM1, ZMYND11, CEBPA, CSK, SNCA, KLF4, PTPN6]
GO:2000781;positive regulation of double-strand break repair;9.0;0.8933024483968273;0.8428918493787028;9.55953138100517;610.2987732095577;6.943860283624253;0.020426150706087248;0.7513499630073597;[BLM, TIMELESS, PARP9]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, FECH, ABCB4, PTAFR, FOXO1, AQP1, ICAM1, GHSR, EDN1, TGFB1, ARG1, RPS6KB1, IL1B]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[PYCARD, PPP2R1A, PRKCD, MAL, S100A9, ATF3, S100A8, NACC2, TP53BP2, SFN, TNFSF12, CAV1, INHBA, BCL2, NOX1, ITM2C, BCL2L1, SRPX, PLEKHF1, CTSH, TIMP3, CASP2, YWHAH, PLAUR, MMP9, SIRT1, TFDP1, LCK, THBS1, E2F1, CTNNA1, GSN, BIK, G0S2, GZMB, PML, PPP1CA, LTBR]
GO:0007051;spindle organization;6.0;0.6873818243518346;0.6668112247660618;8.690254613899192;44.522636097919765;4.786641040901733;0.0014901325624263064;0.5679093580234316;[CEP120, KIF11, CDC20, STMN1, NUF2, FBXO5, TUBG1, ASPM, BIRC5, BIRC2, BIRC3, AURKB, CCNB1, FLNA, RANBP2, RANBP1, STIL, PLK2, NEK7, NDC80, CENPE, KIF4A, RAN, SPC25]
GO:0046939;nucleotide phosphorylation;8.0;0.6729672293956388;0.7114836146978194;8.910684459341805;199.75304005510822;5.6339389012889365;0.006685554484579823;0.6631198974168686;[DTYMK, HK3, BPGM, NME1, RAD50]
GO:1902990;mitotic telomere maintenance via semi-conservative replication;9.0;1.0;0.896240625180289;9.628524252492122;232.51800064843582;8.67846133901236;0.007782168229088393;0.8400575416471059;[PCNA]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[KIF11, AURKB, CDC20, CCNB1, STMN1, NUF2, FLNA, STIL, PLK2, TUBG1, NDC80, CENPE, KIF4A, BIRC5, RAN, BIRC2, SPC25, BIRC3]
GO:0045445;myoblast differentiation;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;6.599019797332524;7.050676185779127E-4;0.587474179321389;[DTYMK, JAG1, LGALS1, IGF1, MAPK14]
GO:0042177;negative regulation of protein catabolic process;7.0;0.7140352122741334;0.7079369713942671;9.105276108727574;231.8232476428224;5.040875179285974;0.007758915471227624;0.6087099563505541;[ALAD, LAMP3, TIMP2, TIMP3, TIMP1, IL10, IRAK3, TAF9, CST3, FLNA, FYN, SNCA, PML, MAD2L1]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, ICAM1, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, F2RL1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, RASAL2, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, ARRB1, TAGAP, ARHGEF12, TBC1D8, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, DOCK2, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[HHEX, ANXA1, HNF1B, E2F7]
GO:0010216;maintenance of DNA methylation;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;8.16763571524637;0.0049883058697239;0.7686126355688037;[DNMT1, UHRF1]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[THBS1, PLN, SPP1, EDN1, DUSP1, CAD, NME1, NASP, RPS6KB1]
GO:1905460;negative regulation of vascular associated smooth muscle cell apoptotic process;10.0;1.0;0.9152410118609203;9.628524252492122;149.61163774803944;9.083926447120524;0.005007366873694588;0.8797934328124444;[DNMT1, IGF1]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[BLM, PCNA, BRCA1, APBB1, H2AFX, PARP9, SIRT1, TIMELESS]
GO:0035234;ectopic germ cell programmed cell death;5.0;1.0;0.7902410118609202;9.628524252492122;49.330608194382684;7.9853141584524145;0.001651051061600959;0.6986103492792611;[IL1A, PRKDC, IL1B, KIT, CASP2]
GO:0090267;positive regulation of mitotic cell cycle spindle assembly checkpoint;13.0;0.9326813400603323;0.9288956347978027;9.597752593825367;471.1536740716433;7.8311634786251565;0.015769089460400346;0.8630410292508717;[NDC80, MAD2L1]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, IFIH1, DHX58, CHUK, SYK, DDX58, RIPK2, MMP12, IRF7, TLR8, TLR7, TLR4, TLR2, PRKDC, HSPD1, PLCG2, CD14, STAT1, NFKB1, NFKB2, MYD88]
GO:1904667;negative regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;755.449957599424;7.57984905034425;0.025284230220031186;0.835754145523778;[FBXO5, MAD2L1]
GO:0046940;nucleoside monophosphate phosphorylation;9.0;0.8436909121759173;0.8180860812682478;9.507163395487854;900.1310122397246;8.16763571524637;0.03012657491434646;0.8139338954918922;[DTYMK]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MED1, MEF2C, HNF1B, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, VIL1, FA2H, BMP2, DAB2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, GREM1, ELF3, TST, RARA, FAM20C, YAP1, TAGLN, CEBPB, CSTA, HDAC2, PCNA, LEF1, RXRA, E2F7, CDX2, KLF4, USH2A, GRHL2]
GO:0006405;RNA export from nucleus;8.0;0.7090535922965819;0.729526796148291;9.033817144745429;77.48498941580046;4.835431205071165;0.0025933528637837495;0.6222841766978864;[, NUP107, HHEX, XPO1, NUP62, MAGOH, NUP133, NCBP2, NUP54, SLBP, NUP205, SEH1L, NUP160, NUP85, NUP43, NUP88, RANBP2, RANBP1, NUP155, UPF3B, NUP35, NUPL2, RAN, NUP37]
GO:0051573;negative regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;805.1350321075869;7.57984905034425;0.026947144950155395;0.8200627852632958;[DNMT1, PAX5, BRCA1, SIRT1]
GO:0001756;somitogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;43.80328827915336;5.845247994956144;0.0014660566383032007;0.5891672661548076;[PRKDC, LEF1, AXIN2, DLL1]
GO:0002328;pro-B cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;23.263450360134797;8.390779266560578;7.786067478076512E-4;0.7522251544931926;[PRKDC, SOX4]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, UHRF1, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, CCNC, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, IGF1, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, NCBP2, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, RBM38, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DNMT1, DAB2, COPS5, MAFB, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RPS6KB1, RBMX]
GO:0060718;chorionic trophoblast cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.16763571524637;7.050676185779127E-4;0.6676932703116032;[FZD5, HTRA1, E2F7]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[DNMT1, MYB, BRCA1]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[BUB1B, AURKB, CDC20, CCNB1, UBE2C, PLK1, CDK1, MAD2L1]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCB, PRKCE, PRKCD, VRK1, PRKCQ, PRKDC, PRKCZ, CCNB1, PLK2, PLK1, CLK1, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, MASTL, SGK1, CAMK2D, AURKB, MAPK14, MAPK13, RPS6KB1, CAMK4, PKN1, CAMK1]
GO:0090309;positive regulation of methylation-dependent chromatin silencing;12.0;1.0;0.9481203125901445;9.628524252492122;1109.1279723986454;8.390779266560578;0.03712151508581291;0.8772251544931927;[DNMT1]
GO:0032877;positive regulation of DNA endoreduplication;10.0;1.0;0.9152410118609203;9.628524252492122;1140.1023815324472;9.083926447120524;0.03815820068436285;0.8797934328124444;[E2F7]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, PRKDC, NEDD4L, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, UBR1, SOCS2, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC2, BIRC3, UHRF1, NLRC4, ZNRF1, RNF24, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, PCNP, NEDD4, KLHL14, DTX3, UBE2C, UBE2M, TNFAIP3, UBE2Q2, HIST1H2BK, RNF6]
GO:0090116;C-5 methylation of cytosine;11.0;0.9326813400603323;0.8987696223598284;9.587702257971866;392.68740709589525;8.67846133901236;0.01314289411977762;0.8762458687964789;[DNMT1]
GO:0008089;anterograde axonal transport;9.0;0.8259837884571596;0.8092325194088689;9.405380701177911;71.1020239957658;6.113511981550823;0.0023797207554711163;0.7088859122241795;[FMR1, RAB21, KIF4A]
GO:0032077;positive regulation of deoxyribonuclease activity;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;813.6405734422207;8.16763571524637;0.027231817764135358;0.7926932703116032;[PCNA, PRKCD, AKT1]
GO:0043045;DNA methylation involved in embryo development;10.0;0.8933024483968273;0.861892236059334;9.548481544818586;558.5396888315765;7.8311634786251565;0.01869382073210792;0.8157270763441555;[DNMT1]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[CDT1, JUN, PCNA, EREG, CST3, DBF4, CDK1, E2F7]
GO:0006342;chromatin silencing;11.0;0.7763722522362496;0.820615078447787;9.454170865347344;1752.5176526080036;5.433268205826786;0.058655188669300654;0.7102865410484548;[SUV39H1, BMI1, H2AFX, SIRT1]
GO:0006227;dUDP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6271.9915988638395;9.083926447120524;0.2099179143880009;0.9126727335416687;[DTYMK]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TIMELESS, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[CYFIP1, AKT1, GHSR, CEACAM1, RAB31, PRKDC, FOXO1, PAK1, STAT1, SORBS1, RPS6KB1]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[CEBPB, DNMT1, ABCB4, UBR1, TNF, SESN3, PDGFD, PDGFC, FYN, PDGFRA, MMP2, CYBB, COL1A1, COL3A1, COL1A2, COL4A1, COL5A2, COL6A1, RRAGD, BCL2L1]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, CEBPB, PCNA, TGFB1, IHH, TYMS, SULF2, NFKBIA, HMOX1, EZH2]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[IL10, JUN, DNMT1, IGFBP5, MMP2, IGF1, MMP9, TNF, GNAI2, PAK1, NR4A3]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, BTG2, PCNA, CCNB1, E2F1, CASP2, SFN, E2F7, SOX4, PLK2, PML, TFDP1, CNOT3, CDK1]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[CDT1, PCNA, RRM2, GFI1, CDC6, TYMS, POLA1, TFDP1, CDC45, CCNE1, E2F1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, MCM7, GMNN, SKP2, CDC25A, DBF4, CDC34, CCNE2, CCNE1, MCM3, MCM4, RHOU, MCM6, BCAT1, MCM2, CUL5, PRIM1, IQGAP3, GSPT1, CDC45, RBBP8, RANBP2, RANBP1, CDT1, CDKN2C, PLK2, RPA1, CDC6, INHBA, POLA1, POLA2, WEE1, CDK6, NASP, RPS6KB1, POLE2, RPA3]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[ARG1, LEF1, TCF7, GATA3, CORO1A, PML, ALAD, IMPDH2, XCL1, MCM2]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MAPK13, MFAP4, NEDD4]
GO:0032466;negative regulation of cytokinesis;7.0;0.7140352122741334;0.7079369713942671;9.015419779605713;142.53412634803104;7.8311634786251565;0.004770488936483034;0.7514054297404357;[E2F7, AURKB]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0033314;mitotic DNA replication checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;738.0966094602528;7.379178354882098;0.02470342927481251;0.8098004765652196;[CDC6, TOPBP1, NAE1]
GO:0072719;cellular response to cisplatin;6.0;1.0;0.8231203125901445;9.628524252492122;120.46332589257861;8.16763571524637;0.004031799107669873;0.7408135829017477;[TIMELESS, HMOX1]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[PCNA, POLD3, POLD1, USP1, SOX4, RFC5, RFC3, RFC4, RFC1, RFC2, RPA1, RPA3, DTL]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, RAD21, PRDM16, NKX2-3, NFE2, SNAI2, BTG2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, DNMT1, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, APBB1, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, COL4A2, TIMELESS, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:1905775;negative regulation of DNA helicase activity;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;205.113589991404;9.777073627680469;0.006864967266765914;0.896240625180289;[MCM2]
GO:0033153;T cell receptor V(D)J recombination;11.0;1.0;0.9324289523296623;9.628524252492122;333.8668407979641;8.16763571524637;0.011174222700858697;0.8501222226412654;[BCL11B, PRKDC, LEF1, TCF7]
GO:0033152;immunoglobulin V(D)J recombination;11.0;0.8933024483968273;0.8790801765280758;9.548481544818586;336.06406537530285;8.390779266560578;0.011247761830088488;0.8615337942327104;[PRKDC]
GO:0006233;dTDP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6271.9915988638395;9.083926447120524;0.2099179143880009;0.9126727335416687;[DTYMK]
GO:1905931;negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching;9.0;1.0;0.896240625180289;9.628524252492122;572.8731837270864;9.777073627680469;0.019173549906952723;0.896240625180289;[DNMT1]
GO:0046604;positive regulation of mitotic centrosome separation;10.0;1.0;0.9152410118609203;9.628524252492122;603.270018576253;7.8311634786251565;0.020190904613979026;0.8157270763441555;[RANBP2, RANBP1]
GO:0006235;dTTP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;6270.758393425197;8.390779266560578;0.20987664011178236;0.8772251544931927;[DTYMK, TYMS]
GO:0097681;double-strand break repair via alternative nonhomologous end joining;10.0;1.0;0.9152410118609203;9.628524252492122;369.5024620707547;9.083926447120524;0.012366914874882012;0.8797934328124444;[PRKDC]
GO:0034080;CENP-A containing nucleosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;242.74046782674554;6.343086423195323;0.00812430500592325;0.7206263598461826;[CENPA, NASP, CENPH, CENPI, CENPK, RUVBL1, CENPL, CENPM, CENPN, CENPO]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[, CDC20, PSMD3, TRIM25, SKP2, CDC34, NEDD4L, HACE1, PLK1, TGFB1I1, KIF14, SIRT1, PSMA5, PSMA6, RNF144B, PSMA3, PSMA4, PSMA2, PCNP, USP1, RANBP2, RANBP1, USP9Y, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, RNF43, PSMD14, CUL5, UBR1, CCNB1, WFS1, UBE2C, CDK1, ARRB1, ARRB2, DTL, BIRC2, UHRF1, VPS4B, RNF6, USP18, AURKB, ZNRF1, TBX21, RNF24, PML]
GO:0048478;replication fork protection;10.0;1.0;0.9152410118609203;9.628524252492122;1135.309178205509;7.57984905034425;0.037997776482613155;0.8028748447945538;[SMARCAL1, BLM, DONSON, TIMELESS, BRCA2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, PRKDC, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0072431;signal transduction involved in mitotic G1 DNA damage checkpoint;10.0;0.9326813400603323;0.8815816818910864;9.60254876608886;717.6624066224118;5.734022359845919;0.02401951489541857;0.7084791820027498;[CDKN1A, BTG2, PCNA, PRKDC, CCNB1, E2F1, CASP2, SFN, E2F7, SOX4, PLK2, PML, TFDP1, CNOT3, CDK1]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, PRKDC, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, SRPX, ADM, CTLA4, TIMP3, ANXA1, DUSP1, RIPK2, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, GADD45B, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, APBB1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, TGM2, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, NFKBID, UBE2M, TNFAIP8, CASP2, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0072711;cellular response to hydroxyurea;6.0;1.0;0.8231203125901445;9.628524252492122;186.99437101104425;7.8311634786251565;0.006258533313731664;0.7236063770733796;[BLM, FMR1, TIMELESS]
